Tuchayi, Sara Moradi
Makrantonaki, Evgenia
Ganceviciene, Ruta
Dessinioti, Clio
Feldman, Steven R.
Zouboulis, Christos C.
Article History
First Online: 17 September 2015
Competing interests
: S.M.T. has no conflicts to disclose. E.M. has received an honorarium and a grant from Immundiagnostik. R.G. is a consultant for L'Oreal, and received honoraria as a speaker for Bioderma, Stiefel/GlaxoSmithKline and LEO Pharma. C.D. has received an honorarium as a speaker for Stiefel/GlaxoSmithKline. S.R.F. is a speaker for Janssen and Taro; he is also a consultant and speaker for Galderma, Stiefel/GlaxoSmithKline, Abbott Laboratories and LEO Pharma. S.R.F. has received grants from Galderma, Janssen, Abbott Laboratories, Amgen, Stiefel/GlaxoSmithKline, Celgene and Anacor. S.R.F. is also a consultant for Amgen, Baxter, Caremark, Gerson Lehrman Group, Guidepoint Global, HanAll Pharmaceutical, Kikaku, Eli Lilly, Merck, Merz, Mylan, Novartis, Pfizer, Qurient, Suncare Research and Xenoport. S.R.F. is on an advisory board for Pfizer. S.R.F. is also the founder of and holds stock in Causa Research, and holds stock and is the majority owner in Medical Quality Enhancement Corporation, and he receives royalties from UpToDate and Xlibris. The Center for Dermatology Research, Wake Forest School of Medicine, North Carolina, USA, is supported by an unrestricted educational grant from Galderma Laboratories. C.C.Z. has received honoraria from AbbVie, Almirall, Basilea, Bayer Health Care, Bioderma, Biogen-Idec, Dermira, Galderma, General Topics, Glenmark, LEO Pharma, Philips Lifestyle, Pierre Fabre, Stiefel/GlaxoSmithKline, Vichy and Xenon for participation on advisory boards, or as a consultant, investigator or speaker. The Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany, have received grants from AbbVie, AstraZeneca, Bioderma, Biogen-Idec, Bristol-Meyers Squibb, Immundiagnostik, Intendis, LVMH, Merz, Novartis, Pierre Fabre, and UCB for the participation of C.C.Z. as an investigator, or on advisory boards.